Ontology highlight
ABSTRACT: Background
Lipid accumulation product (LAP) is an index describing the overaccumulation of lipid. Baseline LAP was used for type 2 diabetes (T2D) prediction in previous studies. But the longitudinal trajectories of LAP, which reflect the efficacy of patients' lipid-lowering treatment and lifestyle improvement, have rarely been studied. The aim of this study is to explore the association of lipid accumulation product trajectories with 5-year incidence of type 2 diabetes.Methods
This cohort study included 4508 non-diabetic participants with a median age of 42?years. Using the group-based trajectory modeling (GBTM), LAP from 2011 to 2016 were determined and identified as three trajectories: low (n?=?3639), moderate (n?=?800), and high (n?=?69). Baseline LAP was divided into groups by percentiles and tertiles respectively for the comparison of LAP trajectories. The associations between 5-year T2D incidence and LAP trajectories and baseline LAP were both assessed by generalized linear models.Results
From 2011 to 2016, 169 participants developed T2D (the 5-year incidence of 3.8%). For participants with low, moderate, and high trajectories, the incidence of T2D was 2.1, 10.0, and 15.9%, respectively. A significant trend was observed in the relative risks (RRs) of 5-year incident T2D in participants with moderate (RR, 1.95; 95% CI: 1.41-2.70) and high LAP trajectory (RR, 2.20; 95% CI: 1.12-4.30) in the fully adjusted model (p for trendConclusionThe trajectories of LAP has an independent effect on 5-year T2D incidence beyond LAP measured at baseline.
SUBMITTER: Yan G
PROVIDER: S-EPMC6802349 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
Yan Guangyu G Li Fei F Elia Christelle C Zhao Yating Y Wang Jiangguang J Chen Zhiheng Z Yuan Hong H Lu Yao Y
Nutrition & metabolism 20191021
<h4>Background</h4>Lipid accumulation product (LAP) is an index describing the overaccumulation of lipid. Baseline LAP was used for type 2 diabetes (T2D) prediction in previous studies. But the longitudinal trajectories of LAP, which reflect the efficacy of patients' lipid-lowering treatment and lifestyle improvement, have rarely been studied. The aim of this study is to explore the association of lipid accumulation product trajectories with 5-year incidence of type 2 diabetes.<h4>Methods</h4>Th ...[more]